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Abstract 
Background : Chronic obstructive pulmonary disease (COPD) is a common  disease and has remarkable effects 
on cardiac functions, including those of the right ventricle, left ventricle, and pulmonary blood vessels. Most of 
the increased mortality associated with COPD is due to cardiac involvement. Echocardiography(Echo) provides 
a rapid, noninvasive, portable, and accurate method to evaluate the cardiac changes. 
Aim of study: To assess cardiac changes secondary to COPD by echocardiography and to find if there is a 
correlation between echocardiographic findings and severity of COPD.  
Materials and Methods: A total 50 of patients with COPD were diagnosed and staged by pulmonary function 
test (PFT) according to GOLD criteria into 4 stages. For all patients, detailed history, carful clinical examination, 
electrocardiography(ECG), chest x ray(CXR), and routine blood tests were done. All patients evaluated by 
echocardiography. 
Results: On echocardiographic evaluation of COPD,40% of  cases had normal echocardiographic parameters. 
Measurable tricuspid regurgitation (TR) was observed in 25/50 (50.0%) of cases . Pulmonary hypertension 
(PHT), which is defined as systolic pulmonary arterial pressure (sPAP)> 30 mmHg was observed in 14/25 
(56.0%) of patients with TR (28.0% of total patients) , in which prevalence of mild, moderate, and severe PHT 
were 7/14 (50.0%), 4/14 (28.6%), and 3/14 (21.4%), respectively. The frequencies of PHT in mild, moderate, 
severe, and very severe COPD were 7.1%, 14.3 %, 35.7%, and 42.9%, respectively. Cor pulmonale was 
observed in 6/14 (42.9%) of cases (12.0% of total patients) ; The frequencies of cor pulmonale  in  patients with  
mild, moderate, and sever PHT were 0 , 75.0% ,100.0 % ,respectively ; 2.0% cases had left ventricle systolic 
dysfunction(LVSD) and 10.0% cases had evidence of left ventricle diastolic dysfunction(LVDD). Left ventricle 
hypertrophy (LVH) was found in 4.0% of cases. 
Conclusion: Prevalence of cardiovascular complications (especially PHT and cor pulmonale) is high among 
COPD patients and has a linear relationship with increasing severity of COPD. Echocardiography helps in early 
detection of cardiac complications in COPD cases giving time for early interventions. 
Keywords: Chronic obstructive pulmonary disease (COPD), Echocardiography(Echo), electrocardiography 
(ECG). 
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Introduction 
Chronic obstructive pulmonary disease (COPD) is a common preventable and 
treatable disease ,characterized mainly by persistent airflow limitation that is usually 
progressive and associated with enhanced chronic inflammatory response in the airways and 
the lungs to noxious particles and gases. (1)  
COPD has a considerable effects on cardiac functions, including effects on the right 
ventricle ,left ventricle, and pulmonary blood vessels(2).It is well established now that 
cardiovascular disease contributes significantly to both morbidity and mortality in COPD (3).  
The cardiovascular sequelae of COPD have been recognized for decades. The 
spectrum of cardiovascular disease includes right ventricular (RV) dysfunction, pulmonary 
hypertension (PHT), coronary artery disease (CAD), and arrhythmias. Pulmonary vascular 
disease associated with COPD increases morbidity and worsens survival. Patients with COPD 
also carry an increased risk of mortality due to arrhythmia, myocardial infarction, or 
congestive heart failure compared with those who do not(4). 
The important notion that COPD itself is an independent risk for CVD has potentially 
important implications. As a systemic inflammatory disease, COPD may accelerate the 
development of cardiovascular disease above and beyond that due to smoking alone(5). 
 A number of population studies have shown that airflow limitation as measured by 
FEV1 or FEV1/FVC ratio is a predictor of cardiovascular risk. The FEV1 is also an 
independent predictor of cardiovascular mortality in COPD (3).. There is also a relationship 
between the rate of decline in FEV1 and cardiovascular disease. 
Echocardiography provides a rapid, noninvasive, portable and accurate method to 
evaluate the cardiac functions including:: right ventricle function, right ventricular filling 
pressure, tricuspid regurgitation, left ventricular function and valvular function. Many studies 
have confirmed that echocardiographically derived estimates of pulmonary arterial pressure 
correlate closely with pressures measured by right heart catheter(RHC) (r> 0.7)(2). The need 
for further invasive diagnostics is often triggered by the Doppler echocardiographic(DE) 
assessment of the peak sPAP. But the reported accuracy of sPAP determination by DE is 
controversial. While initial comparisons between DE and RHC revealed an acceptable 
correlation, more recent studies questioned the diagnostic value of DE in PHT (6). 
The Doppler echographic examination is a central part of the initial diagnosis and 
assessment of patients with pulmonary vascular disease and other forms of pulmonary 
hypertension. Often, the results of the initial DE examination are pivotal in the decision 
making process for which patients are referred for further hemodynamic assessment of their 
PHT  (7). 
Although the exact prevalence of PHT in COPD is not known, an elevation in 
pulmonary arterial pressure is found to occur in 20%–90% of patients when measured by right 
heart catheterization with some evidence that pulmonary hemodynamics  worsen  with 
worsening of airflow obstruction(8,9) .Several studies have shown an abnormal rise in the mean 
pulmonary arterial pressure (mPAP) in COPD of 0.4–0.6 mmHg per year. These studies 
reported that PH in COPD progresses slowly and could occurs in mild as well as severe forms 
of disease(10,11). 
 
Aims of Study  
1. To assess echocardiographic findings in COPD patients. 
2. To assess correlation between echocardiographic findings and severity of COPD. 
 
Patients and Methods 
A cross sectional study carried out in Respiratory Consultation clinic of Baghdad 
Teaching Hospital for the period from 1st of February to the end of June, 2015.  A convenient 
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sample of fifty patients presented with signs and symptoms of COPD were the sample of the 
study. The data were collected by direct interview and fulfilling a prepared questionnaire. 
Diagnosis of COPD was made on basis of detailed history, carful clinical examination 
supported by spirometry, electrocardiographic, and radiological data. The diagnosis of COPD 
was confirmed by a specialist in Respiratory Medicine in Baghdad Teaching Hospital. The 
questionnaire included the followings: 
1. Sociodemographic characteristics: Age, gender and occupation. 
2. Smoking: None, ex or current smoker. 
3. Family history. 
4. Clinical presentation. 
5. ECG findings. 
6. Echocardiographic findings. 
 
Statistical analysis   All patients' data entered using computerized statistical software; 
Statistical Package for Social Sciences (SPSS) version 20 was used. Descriptive statistics 
presented as (mean ± standard deviation) and frequencies as percentages. Kolmogorov 
Smirnov analysis verified the normality of the data set. Multiple contingency tables 
conducted and appropriate statistical tests performed, Chi-square used for categorical 
variables and Fishers exact test was used when expected variables were less than 20%. In all 
statistical analysis, level of significance (p value) set at ≤ 0.05 and the result presented as 
tables and/or graphs.  
 
Results 
A total of 50 COPD patients were included in present study with mean age 58±9 
years, 52% of them were aging 50-59 years. Males were more than females with male to 
female ratio as 7.3:1 
ECG findings were abnormal among 18 COPD patients and Echo findings were 
abnormal among 20 patients. Abnormal Echo findings were shown in table 1. 
 
Table 1: ECG & Echo findings of COPD patients. 
Variable  No. % 
ECG findings  
Normal  32 64.0% 
Abnormal  18 36.0 
Total  50 100.0 
Echocardiography findings 
Normal  20 40.0 
LVDD 5 10.0 
LVSD 1 2.0 
PHT 14 28.0 
Cor-pulmonale  6 12.0 
RHF 1 2.0 
LVH 2 4.0 
RVSD 1 2.0 
Total  50 100.0 
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There was a significant association between abnormal ECG findings of COPD patients 
and very severe COPD (p<0.001). A significant association was observed between COPD 
patients diagnosed as PHT and cor pulmonale with severe and very severe disease (p=0.000). 
Significant  association was observed between PHT severity and COPD severity (p=0.014). 
All these findings were shown in table 2..Also cases of COPD diagnosed as cor pulmonale 
were significantly associated with severe and very severe disease (p<0.05), table 3.  
 
Table 2: Distribution of ECG, Echo and PHT according to severity. 
Variable  Mild  Moderate  Severe  Very severe χ² P  
No. % No. % No. % No. % 
ECG findings  28.2* <0.001 
Normal  19 59.4 11 34.4 2 6.3 0 - 
Abnormal  2 11.1 2 11.1 6 33.3 8 44.4 
Echo findings   79.9* 0.000 
Normal  19 95.0 1 5.0 0 - 0 - 
LVDD 0 - 1 20.0 1 20.0 3 60.0 
PHT 1 7.1 2 14.3 5 35.7 6 42.9 
Cor-
pulmonale    
0 - 0 - 3 50.0 3 50.0 
RHF 0 - 0 - 1 100.0 0 - 
LVH 0 - 0 - 1 50.0 1 50.0 
LVSD 0 - 0 - 0 - 1 100.0 
RVSD 0 - 0 - 0 - 1 100.0 
PHT severity  15.8* 0.014 
Mild  1 14.3 2 28.6 4 57.1 0 - 
Moderate  0 - 0 - 1 25.0 3 57.0 
Severe  0 - 0 - 0 - 3 100.0 
*Fishers exact test. 
 
Table 3: Distribution of  cor  pulmonale according to COPD severity. 
Variable Mild  Moderate  Severe  Very severe χ² P  
No. % No. % No. % No. % 
Cor-pulmonale 9.2* 0.02 
Yes   0 - 0 - 3 50.0 3 50.0 
No  21 47.7 13 29.5 5 11.4 5 11.4 
*Fishers exact test. 
 
The frequencies of cor pulmonale  in  patients with  mild, moderate, and sever PH were 
0 , 75.0% ,100.0 % ,respectively ; so we can see good correlation  between  severity of  PH  
and  the  development  of cor pulmonale, table 4. 
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Table 4 : Frequency of cor pulmonale with severity of PH. 
Severity of PH Frequency of cor pulmonale 
Mild (7) 0(0) 
Moderate (4) 75% (3) 
Severe (3) 100.0 % (3) 
 
There was a significant decrease in FEV1 means associated with Echo findings especially 
with PHT and cor-pulmonale (p<0.001), table 5. 
 
Table 5: ANOVA analysis of FEV1 according to Echo findings. 
Echo findings  FEV1 
Mean±SD 
Normal  77.2±11.2 
LVDD 71.1±19.8 
LVH 70.2±0.9 
PHT 48±18.6 
Cor-pulmonale  36.2±11.3 
RHF 44±0.1 
ANOVA (P value ) <0.001 
 
Discussion 
In present study, abnormal electrocardiography ECG findings were present among 
36% of studied COPD patients.  
We also found that 60% of COPD patients had abnormal echo results. This finding is 
close to results of Gupta NK, et al study in India (2011), which reported that 50% of COPD 
patients had abnormal echo findings(2).The main echo finding among COPD patients was 
pulmonary hypertension which is found to be 28% of various COPD severity ,while in Gupta  
NK, et  al  it was 42.5%(2).  
PHT severity among COPD patients in our study was distributed as followings; 50.0% 
mild, 28.6% moderate and  21.4% severe. This finding is similar to results of Chaouat A, et al 
study in USA (2005)( 12). 
The frequencies of PHT in mild, moderate, severe, and very severe COPD were  7.1% 
, 14.3% , 35.7% , and 42.9% , respectively. In one study it was found to be 25%, 43%, and 
68% in mild, moderate, and severe COPD, respectively(13). In our study also revealed that 
severe PHT is present only in very severe COPD and we  found a significant association 
between each of cor pulmonale and PHT cases with severe and  very severe COPD (p<0.05). 
This finding is similar to results of Shujaat A, et al study in USA (2007)(14). 
So we conclude that the incidence of PHT is directly proportional to the severity of 
disease. This finding is similar to results of Sultan KM, et al study in Iraq (2009)(15) which 
found high prevalence of pulmonary arterial hypertension with increasing severity of COPD. 
 Cor pulmonale is present in 12 % of patients in our study. Approximately 25% 
patients with COPD eventually develop cor pulmonale (16). Cor pulmonale was found in 40% 
of patients with COPD in one autopsy study (17,18). It is estimated that 10% to 30% of  all 
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hospital admissions for heart failure in the United States every year are due to cor 
pulmonale(19) and approximately 85% of  patients with cor pulmonale have COPD.( 16) 
Among COPD patients, there was a significant association between low FEV1 and cor 
pulmonale (p<0.001)(14).  
 Several studies indicate that left ventricular (LV) function remains normal in 
individuals with COPD, whereas others illustrate that LV dysfunction may be present (20,21). 
Abnormal LV performance in individuals with COPD may be attributed to a number of 
factors,like hypoxemia and acidosis; coexisting coronary artery disease; ventricular 
interdependence (because of the right ventricle (RV) and left ventricle(LV) shared a common 
septum, RV dilatation may lead to bulging of the septum into the LV, which leads to increase 
LV end-diastolic pressure, decrease venous return, and diminish LV stroke volume and 
cardiac output and large swings in intrathoracic pressure (22) In our study, left ventricular 
systolic dysfunction (LVSD) is present in 2.0% patients, in previous studies it was present in 
4%–32% patients of COPD(34).Left ventricular diastolic dysfunction(LVDD) was reported in 
COPD patients with normal pulmonary arterial pressure and it increased with RV after 
load(23). In our study LVDD is present in 10.0% of patients, various mechanisms may explain 
the presence of LVDD in COPD patients. This might be due to chronic hypoxemia which lead 
to abnormalities of myocardial relaxation, lung hyperinflation, and distension leading to 
increased stiffness of the parietal pleura and thus of the wall of cardiac fossa leading to added 
load on ventricle, and also due to ventricular interdependence.Left ventricular hypertrophy 
(LVH) was reported in 4% of patients in our study, in one previous study LVH was present in 
25%–60% patients dying of COPD particularly in patient who also had right ventricular 
hypertrophy(24). 
 
Conclusions  
 Prevalence of abnormal echocardiography among COPD patients was high. 
 Pulmonary hypertension and cor pulmonale were more prevalent among severe and very 
severe COPD patients. 
 COPD severity was more likely to be associated with increasing age, intensity of smoking 
and positive family history of COPD. 
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 الخلاصة 
، الايسر مرض الانسداد الرئوي المزمن هو مرض شائع وله تأثيرات كبيرة على وظائف القلب، بما في ذلك من البطين الأيمن، البطين :الخلفية
تخطيط  يوفر. بيةناتجة عن مضاعفات الاصابة القلالمزمن والأوعية الدموية الرئوية وان معظم الزيادة في الوفيات المرتبطة بمرض الانسداد الرئوي 
 .ودقيقة لتقييم التغيرات الحاصلة في القلب باضعة، غير,ى القلب طريقة سريعة، سهلة التنقلصد
ط بين ناك ارتباتقييم التغيرات القلبية الناتجة عن مرض الانسداد الرئوي المزمن عن طريق تخطيط صدى القلب ومعرفة ما إذا كان ه: هدف الدراسة
 >الرئوي المزمن نتائج تخطيط صدى القلب وشدة مرض الانسداد
وفقا  مريض تم تشخيص اصابتهم بمرض الانسداد الرئوي المزمن و تقسيمهم الى أربعة مراحل 05تم اختيار مجموعة مؤلفة من : طريقة البحث
ع عمل لجميع المرضى تم اخذ التاريخ الطبي المفصل وا  جراء فحص سريري دقيق م .لمعايير المبادرة العالمية لمرض الانسداد الرئوي المزمن
 قلبكافة المرضى تم تقييمهم بواسطة تخطيط صدى ال.واختبارات الدم الروتينية,تصوير الصدر بالاشعة السينية ,تخطيط القلب الكهربائي 
لس قوقد لوحظ .الات التي تمت دراستها كانت تحمل معطيات طبيعية ٪ من الح04أظهر تقييم المرضى بواسطة تخطيط صدى القلب ان : النتائج
يان والذي يعرف بانه ارتفاع ضغط دم الشر  الدم الرئوي ارتفاع ضغط . من الحالات) ٪0.05( 05/52الصمام ثلاثي الشرف القابل للقياس في 
% من عدد 82(وجد عندهم قلس الصمام ثلاثي الشرف  %) من المرضى الذين0,65( 52\41 ملم زئبق لوحظ في03الرئوي الانقباضي أكثر من 
معتدل %) 6,82(41\4,خفيف %) 0,05(41\7:كالاتي ) ارتفاع ضغط الدم الرئوي (وقد توزعت شدة المرض المرضى الكلي في الدراسة)
 فيفنسداد الرئوي المزمن الخكما أظهرت الدراسة أن وتيرة ارتفاع ضغط الدم الرئوي بالنسبة لكل من مراحل مرض الا.شديد%) 4,12(41\3,
 أظهرت الدراسة وجود مرض القلب الرئوي في % على التعاقب.9,24% ,7,53% ,3,41% ,1,7,المعتدل ,الشديد ,و الشديد جدا كان كالاتي:
غط ضلحالات ارتفاع من العدد الكلي للمرضى في الدراسة) كما لوحظ ان وتيرة مرض القلب الرئوي بالنسبة  %21%) من الحالات (9,24(41\6
ن م% 2كما لوحظ  اعتلال البطين الايسر الانقباضي في .على التوالي% ,001% ,57الدم الرئوي الخفيف ,المعتدل ,والشديد , كان :صفر ,
ل معد كما وجد ان هنالك انخفاض كبير في.من الحالات% 4وتضخم البطين الايسر في % ,01اعتلال البطين الايسر الانبساطي في ,الحالات 
ب مرض القلبالاخص ارتفاع ضغط الدم الرئوي و (حجم الزفير القسري في ثانية واحدة بالتزامن مع التغييرات المكتشفة بواسطة تخطيط صدى القلب 
 ).الرئوي 
مرض بمصابين عند ال) ط الدم الرئوي ومرض القلب الرئوي وخاصة ارتفاع ضغ(ان معدل انتشار مضاعفات القلب والاوعية الدموية : الاستنتاج
ة عند تخطيط صدى القلب يساعد في الكشف المبكر عن المضاعفات القلبي. الانسداد الرئوي المزمن عال وله علاقة خطية مع زيادة شدة المرض
 للتدخل المبكرمعطيا بذلك الوقت  مرضى الانسداد الرئوي المزمن
 –
